user warning: Got error 28 from storage engine query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 578250 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.

Highest Sales per Share in the Biotechnology Industry Detected for Biogen Idec (BIIB, AMGN, UTHR)

Published on Mon, 10/07/2013 - 11:58
By Mallory Stone

Below are the three companies in the Biotechnology industry with the highest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry.

Biogen Idec (NASDAQ:BIIB) is highest with sales per share of $25.08. Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products addresses diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, crohn's disease, and psoriasis.

In the past 52 weeks, shares of Biogen Idec have traded between a low of $134.00 and a high of $248.95 and are now at $238.95, which is 78% above that low price. The 200-day and 50-day moving averages have moved 1.13% higher and 0.60% higher over the past week, respectively.

Following is Amgen (NASDAQ:AMGN) with sales per share of $23.26.

Finishing up the top three is United Therapeutics (NASDAQ:UTHR), with sales per share of $20.05.

By Mallory Stone
mstone@fnno.com